Evidence map›Paper›PMID 33279932›Full record

ArticleMolecular psychiatry2021

Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population.

Mingrui Li, Yanli Li, Haide Qin, Justin D Tubbs, Minghui Li, Chunhong Qiao, Jinran Lin, Qingyang Li, Fengmei Fan, Mengzhuang Gou and 5 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Schizophrenia: from mechanism to therapy.Science China. Life sciences · 2026
    Review
  3. Article
  4. Article
  5. A comprehensive guide to genomeZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Mingrui Li *Department of Biostatistics and Computational Biology, School of Life Sciences, Fudan University, Shanghai, 200438, PR China.ORCID http://orcid.org/0000-0003-1217-6567
Yanli Li *Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, 100096, PR China.
Haide QinGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.
Justin D TubbsDepartment of Psychiatry, The University of Hong Kong, Hong Kong, SAR, 999077, PR China.ORCID http://orcid.org/0000-0002-6671-6816
Minghui LiSinotech Genomics Ltd, Shanghai, 210000, PR China.
Chunhong QiaoDepartment of Biostatistics and Computational Biology, School of Life Sciences, Fudan University, Shanghai, 200438, PR China.
Jinran LinDepartment of Biostatistics and Computational Biology, School of Life Sciences, Fudan University, Shanghai, 200438, PR China.ORCID http://orcid.org/0000-0002-5786-071X
Qingyang LiDepartment of Biostatistics and Computational Biology, School of Life Sciences, Fudan University, Shanghai, 200438, PR China.
Fengmei FanPeking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, 100096, PR China.ORCID http://orcid.org/0000-0003-1028-6754
Mengzhuang GouPeking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, 100096, PR China.ORCID http://orcid.org/0000-0001-7341-5387
Junchao HuangPeking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, 100096, PR China.
Jinghui TongPeking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, 100096, PR China.
Fude YangPeking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, 100096, PR China.
Yunlong TanPeking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, 100096, PR China. yltan21@126.com.
Yin YaoDepartment of Biostatistics and Computational Biology, School of Life Sciences, Fudan University, Shanghai, 200438, PR China. yin_yao@fudan.edu.cn.ORCID http://orcid.org/0000-0003-3053-8429
Peking University · CNFudan University · CNChinese University of Hong Kong · HKSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is a severe neuropsychiatric disorder with core features including hallucinations, delusions, and cognition deficits. Accumulating evidence has implicated abnormal DNA methylation in the development of schizophrenia. However, the mechanisms by which DNA methylation changes alter the risk for schizophrenia remain largely unknown. We recently carried out a DNA methylome study of peripheral blood samples from 469 first-episode patients with schizophrenia and 476 age- and gender-matched healthy controls of Han Chinese origin. Genomic DNA methylation patterns were quantified using an Illumina Infinium Human MethylationEPIC BeadChip. We identified multiple differentially methylated positions (DMPs) and regions between patients and controls. The most significant DMPs were annotated to genes C17orf53, THAP1 and KCNQ4 (K

Indexed as

DNA MethylationSchizophreniaAsian PeopleBlood CellsChinaCpG IslandsEpigenesis, GeneticHumans

Identifiers

PMID33279932
OpenAlexW3112871028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.